Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.

Gaig C, Compta Y.

Curr Opin Neurol. 2019 Jan 28. doi: 10.1097/WCO.0000000000000677. [Epub ahead of print]

PMID:
30694925
2.

A comprehensive screening of copy number variability in dementia with Lewy bodies.

Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J.

Neurobiol Aging. 2019 Mar;75:223.e1-223.e10. doi: 10.1016/j.neurobiolaging.2018.10.019. Epub 2018 Oct 24.

PMID:
30448004
3.

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson's Disease.

Uribe C, Segura B, Baggio HC, Campabadal A, Abos A, Compta Y, Marti MJ, Valldeoriola F, Bargallo N, Junque C.

Front Aging Neurosci. 2018 Oct 11;10:325. doi: 10.3389/fnagi.2018.00325. eCollection 2018.

4.

Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.

Valldeoriola F, Muñoz E, Rumià J, Roldán P, Cámara A, Compta Y, Martí MJ, Tolosa E.

Parkinsonism Relat Disord. 2018 Sep 5. pii: S1353-8020(18)30393-6. doi: 10.1016/j.parkreldis.2018.09.008. [Epub ahead of print]

5.

Diagnostic Accuracy, Item Analysis and Age Effects of the UPSIT Spanish Version in Parkinson's Disease.

Campabadal A, Segura B, Baggio HC, Abos A, Uribe C, Garcia-Diaz AI, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Arch Clin Neuropsychol. 2018 Jul 11. doi: 10.1093/arclin/acy053. [Epub ahead of print]

PMID:
30007334
6.

Gray/White Matter Contrast in Parkinson's Disease.

Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Front Aging Neurosci. 2018 Mar 27;10:89. doi: 10.3389/fnagi.2018.00089. eCollection 2018.

7.

Cerebrospinal fluid levels of alpha-synuclein in PARKINSON'S disease: Another long and winding road.

Markopoulou K, Compta Y.

Parkinsonism Relat Disord. 2018 Apr;49:1-3. doi: 10.1016/j.parkreldis.2018.02.035. No abstract available.

PMID:
29548634
8.

α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M; Barcelona LRRK2 Study Group†.

Mov Disord. 2018 Apr;33(4):637-641. doi: 10.1002/mds.27295. Epub 2018 Feb 23.

PMID:
29473656
9.

Statistical inference in brain graphs using threshold-free network-based statistics.

Baggio HC, Abos A, Segura B, Campabadal A, Garcia-Diaz A, Uribe C, Compta Y, Marti MJ, Valldeoriola F, Junque C.

Hum Brain Mapp. 2018 Jun;39(6):2289-2302. doi: 10.1002/hbm.24007. Epub 2018 Feb 15.

PMID:
29450940
10.

Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.

Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C.

Parkinsonism Relat Disord. 2018 May;50:3-9. doi: 10.1016/j.parkreldis.2018.02.006. Epub 2018 Feb 8.

11.

Ubiquinone, ubiquinol, 4-hydroxybenzoic acid… What 'coenzyme Q10' should we care about in multiple system atrophy?

Compta Y, Muñoz E, Martí MJ.

Parkinsonism Relat Disord. 2018 May;50:117-118. doi: 10.1016/j.parkreldis.2018.01.020. Epub 2018 Feb 5. No abstract available.

PMID:
29433994
12.

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J.

Lancet Neurol. 2018 Jan;17(1):64-74. doi: 10.1016/S1474-4422(17)30400-3. Epub 2017 Dec 16.

13.

l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior.

Valldeoriola F, Santacruz P, Ríos J, Compta Y, Rumià J, Muñoz JE, Martí MJ, Tolosa E.

Brain Behav. 2017 Oct 20;7(11):e00848. doi: 10.1002/brb3.848. eCollection 2017 Nov.

14.

Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.

Garcia-Diaz AI, Segura B, Baggio HC, Uribe C, Campabadal A, Abos A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Parkinsonism Relat Disord. 2018 Jan;46:62-68. doi: 10.1016/j.parkreldis.2017.11.003. Epub 2017 Nov 7.

15.

Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?

Compta Y, Martí MJ.

Nat Rev Neurol. 2017 Dec;13(12):709-710. doi: 10.1038/nrneurol.2017.159. Epub 2017 Nov 10. No abstract available.

PMID:
29123250
16.

Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.

Compta Y, Giraldo DM, Muñoz E, Antonelli F, Fernández M, Bravo P, Soto M, Cámara A, Torres F, Martí MJ; Catalan MSA Registry (CMSAR).

Parkinsonism Relat Disord. 2018 Jan;46:16-23. doi: 10.1016/j.parkreldis.2017.10.010. Epub 2017 Oct 20.

PMID:
29107645
17.

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer.

Barrantes S, Sánchez Egea AJ, González Rojas HA, Martí MJ, Compta Y, Valldeoriola F, Simo Mezquita E, Tolosa E, Valls-Solè J.

PLoS One. 2017 Aug 25;12(8):e0183843. doi: 10.1371/journal.pone.0183843. eCollection 2017.

18.

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson's Disease.

Garcia-Diaz AI, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Uribe C, Campabadal A, Abos A, Junque C.

J Int Neuropsychol Soc. 2018 Jan;24(1):33-44. doi: 10.1017/S1355617717000583. Epub 2017 Jul 17.

19.

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.

Alcolea D, Vilaplana E, Suárez-Calvet M, Illán-Gala I, Blesa R, Clarimón J, Lladó A, Sánchez-Valle R, Molinuevo JL, García-Ribas G, Compta Y, Martí MJ, Piñol-Ripoll G, Amer-Ferrer G, Noguera A, García-Martín A, Fortea J, Lleó A.

Neurology. 2017 Jul 11;89(2):178-188. doi: 10.1212/WNL.0000000000004088. Epub 2017 Jun 7.

PMID:
28592456
20.

Quick outpatient diagnosis in small district or general tertiary hospitals: A comparative observational study.

Montori-Palacín E, Prieto-González S, Carrasco-Miserachs I, Altes-Capella J, Compta Y, López-Soto A, Bosch X.

Medicine (Baltimore). 2017 Jun;96(22):e6886. doi: 10.1097/MD.0000000000006886.

21.

Brain correlates of progressive olfactory loss in Parkinson's disease.

Campabadal A, Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Parkinsonism Relat Disord. 2017 Aug;41:44-50. doi: 10.1016/j.parkreldis.2017.05.005. Epub 2017 May 10.

22.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Review.

23.

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.

24.

Clinical manifestations of the anti-IgLON5 disease.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, Seitz C, Simabukuro M, Téllez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaría J, Dalmau J.

Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5.

25.

Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning.

Abós A, Baggio HC, Segura B, García-Díaz AI, Compta Y, Martí MJ, Valldeoriola F, Junqué C.

Sci Rep. 2017 Mar 28;7:45347. doi: 10.1038/srep45347.

26.

Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease.

Modreanu R, Cerquera SC, Martí MJ, Ríos J, Sánchez-Gómez A, Cámara A, Fernández M, Compta Y.

J Neurol Sci. 2017 Feb 15;373:223-229. doi: 10.1016/j.jns.2016.12.064. Epub 2016 Dec 30.

PMID:
28131192
27.

Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.

Buongiorno M, Antonelli F, Compta Y, Fernandez Y, Pavia J, Lomeña F, Ríos J, Ramírez I, García JR, Soler M, Cámara A, Fernández M, Basora M, Salazar F, Sanchez-Etayo G, Valldeoriola F, Barrio JR, Marti MJ.

J Alzheimers Dis. 2017;55(3):1261-1272.

PMID:
27814297
28.

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.

Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleó A, Morenas-Rodríguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J.

Neurobiol Aging. 2017 Jan;49:214.e13-214.e15. doi: 10.1016/j.neurobiolaging.2016.08.023. Epub 2016 Sep 2.

29.

Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study.

Vilas D, Segura B, Baggio HC, Pont-Sunyer C, Compta Y, Valldeoriola F, José Martí M, Quintana M, Bayés A, Hernández-Vara J, Calopa M, Aguilar M, Junqué C, Tolosa E; the Barcelona LRRK2 Study Group.

Mov Disord. 2016 Dec;31(12):1820-1828. doi: 10.1002/mds.26799. Epub 2016 Sep 21.

PMID:
27653520
30.

Conjoint FTLD-FUS of the neuronal intermediate filament inclusion disease type, progressive supranuclear palsy and Alzheimer's pathology presenting as parkinsonism with early falls and late hallucinations, psychosis and dementia.

Compta Y, Ramos-Campoy O, Grau-Rivera O, Colom-Cadena M, Clarimón J, Martí MJ, Gelpi E.

Neuropathol Appl Neurobiol. 2017 Jun;43(4):352-357. doi: 10.1111/nan.12340. No abstract available.

PMID:
27490935
31.

White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.

Compta Y, Buongiorno M, Bargalló N, Valldeoriola F, Muñoz E, Tolosa E, Ríos J, Cámara A, Fernández M, Martí MJ.

J Neurol Sci. 2016 Aug 15;367:284-90. doi: 10.1016/j.jns.2016.06.009. Epub 2016 Jun 11. No abstract available.

PMID:
27423605
33.

Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?

Yarnall AJ, Lashley T, Ling H, Lees AJ, Coleman SY, O'Sullivan SS, Compta Y, Revesz T, Burn DJ.

Mov Disord. 2016 May;31(5):668-75. doi: 10.1002/mds.26422. Epub 2015 Oct 13.

PMID:
27156393
34.

Patterns of cortical thinning in nondemented Parkinson's disease patients.

Uribe C, Segura B, Baggio HC, Abos A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Mov Disord. 2016 May;31(5):699-708. doi: 10.1002/mds.26590. Epub 2016 Apr 20.

35.

Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.

Sierra M, Gelpi E, Martí MJ, Compta Y.

Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1.

PMID:
26810462
36.

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.

Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK; International Parkinson's Disease Genomics Consortium (IPDGC), Dickson D, Hardy J, Singleton A, Bras J.

Neurobiol Aging. 2016 Feb;38:214.e7-214.e10. doi: 10.1016/j.neurobiolaging.2015.10.028. Epub 2015 Nov 2.

37.

Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease.

Vallderiola F, Compta Y, Aparicio J, Tarradellas J, Salazar G, Oliver JM, Callén A, Delgado T, Nobbe F.

Parkinsons Dis. 2015;2015:475630. doi: 10.1155/2015/475630. Epub 2015 Oct 21.

38.

Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.

Vilas D, Ispierto L, Álvarez R, Pont-Sunyer C, Martí MJ, Valldeoriola F, Compta Y, de Fabregues O, Hernández-Vara J, Puente V, Calopa M, Jaumà S, Campdelacreu J, Aguilar M, Quílez P, Casquero P, Lomeña F, Ríos J, Tolosa E.

Parkinsonism Relat Disord. 2015 Oct;21(10):1170-6. doi: 10.1016/j.parkreldis.2015.08.007. Epub 2015 Aug 12.

PMID:
26306001
39.

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.

Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A, Calopa M, Casquero P, de Fàbregues O, Jaumà S, Puente V, Salamero M, José Martí M, Santamaría J, Tolosa E.

PLoS One. 2015 Jul 15;10(7):e0132368. doi: 10.1371/journal.pone.0132368. eCollection 2015.

40.

Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy.

Baggio HC, Segura B, Garrido-Millan JL, Marti MJ, Compta Y, Valldeoriola F, Tolosa E, Junque C.

Mov Disord. 2015 Apr 15;30(5):671-9. doi: 10.1002/mds.26137. Epub 2015 Jan 20.

PMID:
25600482
41.

Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease.

Garcia-Diaz AI, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Vendrell P, Bargallo N, Tolosa E, Junque C.

Parkinsonism Relat Disord. 2014 Dec;20(12):1405-10. doi: 10.1016/j.parkreldis.2014.10.014. Epub 2014 Oct 19.

PMID:
25457818
42.

The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).

Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, Mas N, Hofeneder D, Brücke T, Bayés A, Wenzel K, Infante J, Zach H, Pirker W, Posada IJ, Álvarez R, Ispierto L, De Fàbregues O, Callén A, Palasí A, Aguilar M, Martí MJ, Valldeoriola F, Salamero M, Poewe W, Tolosa E.

Mov Disord. 2015 Feb;30(2):229-37. doi: 10.1002/mds.26077. Epub 2014 Dec 1.

PMID:
25449044
43.

Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.

Compta Y, Valente T, Saura J, Segura B, Iranzo Á, Serradell M, Junqué C, Tolosa E, Valldeoriola F, Muñoz E, Santamaria J, Cámara A, Fernández M, Fortea J, Buongiorno M, Molinuevo JL, Bargalló N, Martí MJ.

J Neurol. 2015 Feb;262(2):294-306. doi: 10.1007/s00415-014-7560-z. Epub 2014 Nov 8.

PMID:
25380583
44.

Cognitive impairment and resting-state network connectivity in Parkinson's disease.

Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junqué C.

Hum Brain Mapp. 2015 Jan;36(1):199-212. doi: 10.1002/hbm.22622. Epub 2014 Aug 28.

PMID:
25164875
45.

Cortical thinning associated with mild cognitive impairment in Parkinson's disease.

Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C.

Mov Disord. 2014 Oct;29(12):1495-503. doi: 10.1002/mds.25982. Epub 2014 Aug 7.

PMID:
25100674
46.

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Dec 1;23(23):6139-46. doi: 10.1093/hmg/ddu334. Epub 2014 Jun 27.

47.

A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaría J, Dalmau J, Graus F.

Lancet Neurol. 2014 Jun;13(6):575-86. doi: 10.1016/S1474-4422(14)70051-1. Epub 2014 Apr 3. Erratum in: Lancet Neurol. 2015 Jan;14(1):28.

48.

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.

Botta-Orfila T, Morató X, Compta Y, Lozano JJ, Falgàs N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernández M, Molinuevo JL, Antonell A, Martí MJ, Fernández-Santiago R, Ezquerra M.

J Neurosci Res. 2014 Aug;92(8):1071-7. doi: 10.1002/jnr.23377. Epub 2014 Mar 20.

PMID:
24648008
49.

Functional brain networks and cognitive deficits in Parkinson's disease.

Baggio HC, Sala-Llonch R, Segura B, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junqué C.

Hum Brain Mapp. 2014 Sep;35(9):4620-34. doi: 10.1002/hbm.22499. Epub 2014 Mar 17.

PMID:
24639411
50.

Cystatin C is differentially involved in multiple system atrophy phenotypes.

Urbizu A, Canet-Pons J, Munoz-Marmol AM, Aldecoa I, Lopez MT, Compta Y, Alvarez R, Ispierto L, Tolosa E, Ariza A, Beyer K.

Neuropathol Appl Neurobiol. 2015 Jun;41(4):507-19. doi: 10.1111/nan.12134.

PMID:
24606172

Supplemental Content

Loading ...
Support Center